Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marcos C L Virmond"'
Autor:
Liesbeth F Mieras, Anna T Taal, Wim H van Brakel, Emmanuelle Cambau, Paul R Saunderson, W Cairns S Smith, Cita Rosita S Prakoeswa, Linda Astari, David M Scollard, Dejair Caitano do Nascimento, Jacques Grosset, Hemanta K Kar, Shinzo Izumi, Laura Gillini, Marcos C L Virmond, Marieke G G Sturkenboom
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract The ongoing transmission of Mycobacterium (M.) leprae reflected in a very slow decline in leprosy incidence, forces us to be innovative and conduct cutting-edge research. Single dose rifampicin (SDR) as post-exposure prophylaxis (PEP) for co
Externí odkaz:
https://doaj.org/article/dcd880930d4c4ebf981b570331abf17d
Autor:
Mariane M A Stefani, Charlotte Avanzi, Samira Bührer-Sékula, Andrej Benjak, Chloé Loiseau, Pushpendra Singh, Maria A A Pontes, Heitor S Gonçalves, Emerith M Hungria, Philippe Busso, Jérémie Piton, Maria I S Silveira, Rossilene Cruz, Antônio Schetinni, Maurício B Costa, Marcos C L Virmond, Suzana M Diorio, Ida M F Dias-Baptista, Patricia S Rosa, Masanori Matsuoka, Maria L F Penna, Stewart T Cole, Gerson O Penna
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 11, Iss 6, p e0005598 (2017)
Since leprosy is both treated and controlled by multidrug therapy (MDT) it is important to monitor recurrent cases for drug resistance and to distinguish between relapse and reinfection as a means of assessing therapeutic efficacy. All three objectiv
Externí odkaz:
https://doaj.org/article/91540a58ac934e209d0d7e74859d55f7
Autor:
Patrick R N A G, Stump, Rosemari, Baccarelli, Lúcia H S C, Marciano, José R P, Lauris, Manoel Jacobsen, Teixeira, Somei, Ura, Marcos C L, Virmond
Publikováno v:
International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 72(2)
The introduction of multidrug therapy by the World Health Organization has dramatically reduced the world prevalence of leprosy but the disease is still a public health problem in many countries, with a world prevalence of almost 600,000 cases in 200